RxDoctor Payments Data

Mary Depper, MD

Family Medicine · Mountain Home, ARNPI 1306375084

Payments from drug & device makers

$256in general payments, 2019–2025

Across 7 payments — averaging $36.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$107
  • Exact Sciences$62
  • GSK$32
  • Pfizer$23
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$19
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$12

What the payments were for

  • Food & beverage$256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$256 in reported general payments places this provider in the 35th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$192,924
Medicare patients
261
Services billed
2,928

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban96$83,946
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$52,435
JardianceEmpagliflozin38$43,450
XareltoRivaroxaban39$30,698
TrulicityDulaglutide17$27,301
JanuviaSitagliptin Phosphate19$18,472
Fondaparinux Sodium14$16,198
CreonLipase/Protease/Amylase12$13,828
Repatha SyringeEvolocumab14$12,253
Tresiba Flextouch U-200Insulin Degludec11$11,091
Breo ElliptaFluticasone/Vilanterol12$9,349
KeppraLevetiracetam18$9,227
Albuterol Sulfate HfaAlbuterol Sulfate170$5,244
Advair HfaFluticasone Propion/Salmeterol11$4,526
Potassium Chloride148$2,968

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$23$83,94696 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$32$64,31888 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Mountain Home

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →